Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

148 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Five-year haemodynamic outcomes of the first-generation SAPIEN balloon-expandable transcatheter heart valve.
Sawaya F, Kappetein AP, Wisser W, Nataf P, Thomas M, Schächinger V, De Bruyne B, Eltchaninoff H, Thielmann M, Himbert D, Romano M, Wimmer-Greinecker G, Serruys P, Lefèvre T. Sawaya F, et al. Among authors: schachinger v. EuroIntervention. 2016 Aug 20;12(6):775-82. doi: 10.4244/EIJV12I6A126. EuroIntervention. 2016. PMID: 27542791 Free article. Clinical Trial.
One year follow-up of the multi-centre European PARTNER transcatheter heart valve study.
Lefèvre T, Kappetein AP, Wolner E, Nataf P, Thomas M, Schächinger V, De Bruyne B, Eltchaninoff H, Thielmann M, Himbert D, Romano M, Serruys P, Wimmer-Greinecker G; PARTNER EU Investigator Group. Lefèvre T, et al. Among authors: schachinger v. Eur Heart J. 2011 Jan;32(2):148-57. doi: 10.1093/eurheartj/ehq427. Epub 2010 Nov 12. Eur Heart J. 2011. PMID: 21075775 Free PMC article.
The impact of pre-procedure heart rate on adverse clinical outcomes in patients undergoing percutaneous coronary intervention: Results from a 2-year follow-up of the GLOBAL LEADERS trial.
Wang R, Takahashi K, Chichareon P, Gao C, Kogame N, Modolo R, Tomaniak M, Kawashima H, Ono M, Hara H, Schächinger V, Tonev G, Ungi I, Botelho R, Eeckhout E, Hamm C, Jüni P, Vranckx P, Windecker S, Garg S, Van Geuns RJ, Onuma Y, Serruys PW. Wang R, et al. Among authors: schachinger v. Atherosclerosis. 2020 Jun;303:1-7. doi: 10.1016/j.atherosclerosis.2020.04.010. Epub 2020 Apr 28. Atherosclerosis. 2020. PMID: 32450456 Free article.
Interdisciplinary consensus on indications for transfemoral transcatheter aortic valve implantation (TF-TAVI) : Joint Consensus Document of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte e.V. (ALKK) and cooperating Cardiac Surgery Departments.
von Scheidt W, Welz A, Pauschinger M, Fischlein T, Schächinger V, Treede H, Zahn R, Hennersdorf M, Albes JM, Bekeredjian R, Beyer M, Brachmann J, Butter C, Bruch L, Dörge H, Eichinger W, Franke UFW, Friedel N, Giesler T, Gradaus R, Hambrecht R, Haude M, Hausmann H, Heintzen MP, Jung W, Kerber S, Mudra H, Nordt T, Pizzulli L, Sack FU, Sack S, Schumacher B, Schymik G, Sechtem U, Stellbrink C, Stumpf C, Hoffmeister HM. von Scheidt W, et al. Among authors: schachinger v. Clin Res Cardiol. 2020 Jan;109(1):1-12. doi: 10.1007/s00392-019-01528-5. Epub 2019 Aug 13. Clin Res Cardiol. 2020. PMID: 31410547
2-Year Clinical Outcomes of an Abluminal Groove-Filled Biodegradable-Polymer Sirolimus-Eluting Stent Compared With a Durable-Polymer Everolimus-Eluting Stent.
Xu B, Saito Y, Baumbach A, Kelbæk H, van Royen N, Zheng M, Morel MA, Knaapen P, Slagboom T, Johnson TW, Vlachojannis G, Arkenbout KE, Holmvang L, Janssens L, Ochala A, Brugaletta S, Naber CK, Anderson R, Rittger H, Berti S, Barbato E, Toth GG, Maillard L, Valina C, Buszman P, Thiele H, Schächinger V, Lansky A, Wijns W; TARGET AC Investigators. Xu B, et al. Among authors: schachinger v. JACC Cardiovasc Interv. 2019 Sep 9;12(17):1679-1687. doi: 10.1016/j.jcin.2019.05.001. Epub 2019 May 22. JACC Cardiovasc Interv. 2019. PMID: 31129092 Free article. Clinical Trial.
The STS score is the strongest predictor of long-term survival following transcatheter aortic valve implantation, whereas access route (transapical versus transfemoral) has no predictive value beyond the periprocedural phase.
Hemmann K, Sirotina M, De Rosa S, Ehrlich JR, Fox H, Weber J, Moritz A, Zeiher AM, Hofmann I, Schächinger V, Doss M, Sievert H, Fichtlscherer S, Lehmann R. Hemmann K, et al. Among authors: schachinger v. Interact Cardiovasc Thorac Surg. 2013 Aug;17(2):359-64. doi: 10.1093/icvts/ivt132. Epub 2013 May 3. Interact Cardiovasc Thorac Surg. 2013. PMID: 23644728 Free PMC article.
Abluminal groove-filled biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent: three-year results of the TARGET All Comers trial.
Saito Y, Kelbæk H, Xu B, Hussain Y, Anderson R, Schächinger V, Zheng M, Wijns W, Baumbach A, Lansky AJ. Saito Y, et al. Among authors: schachinger v. EuroIntervention. 2021 Jul 20;17(4):e332-e334. doi: 10.4244/EIJ-D-20-00344. EuroIntervention. 2021. PMID: 32482617 Free PMC article. No abstract available.
148 results